Coronary Disease - Other
This article presents a succinct but comprehensive expert viewpoint on support in cardiogenic shock using the manuscript of the DanGer trial on promising results of Impella in a highly selected subgroup. With only 360 patients...
Novo Nordisk reported that the ZEUS study, which involved more than 6,300 patients with heart disease or advanced kidney disease, failed to show a benefit for ziltivekimab vs placebo. Ziltivekimab...
This study evaluated the outcomes after the use of cardiac shockwave therapy (SWT) combined with coronary artery bypass surgery (CABG) in patients with reduced left ventricular ejection fraction (LVEF) due...
The prevalence of anomalous aortic origin of a coronary artery is 0.4 percent to 0.8 percent. The decision to operate and choice of procedure can be challenging. This invited expert...
This article presents a succinct but comprehensive expert viewpoint on support in cardiogenic shock using the manuscript of the DanGer trial on promising results of Impella in a highly selected...
Abdelhadi Ismail of the Southampton University Hospitals Trust in the UK presents an educational series on cardiac anatomy in which he discusses some of the fundamental concepts. The optimal way...
Ticagrelor (Brilinta), an oral P2Y12 inhibitor, is an agent used in combination with aspirin for dual antiplatelet therapy after coronary interventions. It’s antiplatelet function cannot be reversed by platelet transfusion....
Patient Care and General Interest A roadside thoracotomy was performed in the UK to control severe bleeding for a man who was stabbed, and the procedure was captured on video....
Patient Care and General Interest Uruguay’s fight against tobacco and Phillip Morris was highlighted at the recent Annual Meeting of the American College of Cardiology, and one physician shares her...
Patient Care and General Interest Washington state will increase the age at which people can purchase tobacco and vaping products to 21, part of a growing Tobacco 21 law movement...
A robust meta-analysis of randomized controlled trials on stem cell therapies for refractory angina, offering some encouragement.
...The American College of Cardiology’s 68th Annual Scientific Session has released the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. This guideline includes newly generated recommendations for control...
Very useful open access review, especially the simple figure on page 959.
...

